Related Experiment Video
Updated: Mar 2, 2026

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
Published on: October 6, 2023
Myopathy in Pediatric Thyroid States: A Review of the Literature
Elena Dingle1, Resmy Palliyil-Gopi, Maria Contreras2
1Department of Pediatrics, Division of Pediatric Endocrinology, New York University School of Medicine, New York, NY, USA.
Insights
Thyroid disease can cause myopathy in children. Consider muscle weakness or enzyme changes in children with thyroid conditions for proper diagnosis and treatment.
Area of Science:
- Pediatric Endocrinology
- Neuromuscular Disorders
Background:
- Thyroid dysfunction, encompassing hypothyroidism and hyperthyroidism, can manifest with various clinical presentations.
- Myopathy, a disorder of muscle tissue, is a recognized but often overlooked complication of thyroid disease in pediatric populations.
Purpose of the Study:
- To review the clinical presentations, pathophysiology, diagnostic approaches, and treatment strategies for myopathy in children with thyroid disease.
- To emphasize the importance of considering myopathy in the differential diagnosis of pediatric neuromuscular weakness associated with thyroid dysfunction.
Main Methods:
- Comprehensive literature review of studies on pediatric myopathy and thyroid disease.
- Analysis of case reports and clinical series detailing muscle involvement in hypothyroid and hyperthyroid children.
Main Results:
- Myopathy presents diversely in children with thyroid disease, ranging from proximal muscle weakness to elevated muscle enzymes.
- Both hypothyroidism and hyperthyroidism are associated with distinct pathophysiological mechanisms leading to muscle impairment.
- Early recognition and management of thyroid-related myopathy are crucial for improving patient outcomes.
Conclusions:
- Myopathy should be a key consideration in the diagnostic workup of children presenting with unexplained muscular weakness or elevated muscle enzymes, particularly in the presence of thyroid disease.
- Integrated management addressing both the thyroid dysfunction and the myopathy is essential for effective treatment in pediatric patients.
- Further research is warranted to elucidate the specific molecular pathways involved in pediatric thyroid-associated myopathies.
Abstract:
This review highlights the presentations of myopathy in children in both hypothyroid and hyperthyroid states with an emphasis on the pathophysiology, diagnosis and treatment. Based on our review of the literature data, myopathy should be considered in all children presenting with muscular weakness or altered muscle enzymes in the context of thyroid disease.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Synthesis and Regulation of Thyroid Hormones
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Functions of Thyroid Hormones
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
Chemical Synapses
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...

